Dr Reddy’s Laboratories on Monday said the European Commission has granted marketing authorisation for its biosimilar to ...

Dr. Reddy's Laboratories has achieved a significant regulatory win with the European Commission approving AVT03, its ...

Prolia is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk of fractures.

Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.

Dr Reddys Laboratories announced that the European Commission (EC) has granted marketing authorization for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab).

For many years, older adult patients who fractured their hip typically spent most of their recovery time with orthopedic ...

Analysis of human samples and mouse models shows inflammasome signaling drives bone resorption in males but not females, ...

Dr. Reddy’s secures European Commission approval for AVT03, a biosimilar of Prolia and Xgeva, enhancing its market presence.

Lebanon basketball player Jayden Bailey was diagnosed with cancer when he was 12, had his left arm amputated when he was 16 ...

If you’re considering tooth replacement in Elgin, you’ll find that dental implants stand as the gold standard. These implants ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...